APO Research
Talk to an analyst

APO RESEARCH · REPORT

CRISPR-Cas9 Gene Editing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global CRISPR-Cas9 Gene Editing Service Market Analysis and Forecast 2026-2032

17 January 2026193 pages

Choose your research edition.

Industry ResearchCRISPR-Cas9 Gene Editing Service Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal CRISPR-Cas9 Gene Editing Service Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal CRISPR-Cas9 Gene Editing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CRISPR-Cas9 Gene Editing Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal CRISPR-Cas9 Gene Editing Service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global CRISPR-Cas9 Gene Editing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for CRISPR-Cas9 Gene Editing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for CRISPR-Cas9 Gene Editing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for CRISPR-Cas9 Gene Editing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for CRISPR-Cas9 Gene Editing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of CRISPR-Cas9 Gene Editing Service include AMSBIO, GenScript, Merck, Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, DefiniGEN, Synthego and Biocytogen, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for CRISPR-Cas9 Gene Editing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of CRISPR-Cas9 Gene Editing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for CRISPR-Cas9 Gene Editing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the CRISPR-Cas9 Gene Editing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global CRISPR-Cas9 Gene Editing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for CRISPR-Cas9 Gene Editing Service revenue, projected growth trends, production technology, application and end-user industry.

CRISPR-Cas9 Gene Editing Service Segment by Company

AMSBIO

GenScript

Merck

Editas Medicine

Intellia Therapeutics

CRISPR Therapeutics

DefiniGEN

Synthego

Biocytogen

Caribou

Horizo​​n Discovery Ltd.

EdiGene, Inc.

DetaiBio

CRISPR-Cas9 Gene Editing Service Segment by Type

Knock-in Gene Editing Service

Knock-out Gene Editing Service

Other

CRISPR-Cas9 Gene Editing Service Segment by Application

Cell Line Construction

Animal Models

Bioagriculture

Other

CRISPR-Cas9 Gene Editing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRISPR-Cas9 Gene Editing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CRISPR-Cas9 Gene Editing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRISPR-Cas9 Gene Editing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of CRISPR-Cas9 Gene Editing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of CRISPR-Cas9 Gene Editing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CRISPR-Cas9 Gene Editing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global CRISPR-Cas9 Gene Editing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Knock-in Gene Editing Service Major Player Table 3. Knock-out Gene Editing Service Major Player Table 4. Other Major Player Table 5. Global CRISPR-Cas9 Gene Editing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cell Line Construction Major Player Table 7. Animal Models Major Player Table 8. Bioagriculture Major Player Table 9. Other Major Player Table 10. CRISPR-Cas9 Gene Editing Service Industry Trends Table 11. CRISPR-Cas9 Gene Editing Service Industry Drivers Table 12. CRISPR-Cas9 Gene Editing Service Industry Opportunities and Challenges Table 13. CRISPR-Cas9 Gene Editing Service Industry Restraints Table 14. Global CRISPR-Cas9 Gene Editing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global CRISPR-Cas9 Gene Editing Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global CRISPR-Cas9 Gene Editing Service Market Share by Region (2021-2026) Table 17. Global CRISPR-Cas9 Gene Editing Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global CRISPR-Cas9 Gene Editing Service Market Share by Region (2027-2032) Table 19. Global CRISPR-Cas9 Gene Editing Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Players (2021-2026) Table 21. Global CRISPR-Cas9 Gene Editing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global CRISPR-Cas9 Gene Editing Service Key Players Headquarters & Area Served Table 23. Global CRISPR-Cas9 Gene Editing Service Players, Product Type & Application Table 24. Global CRISPR-Cas9 Gene Editing Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global CRISPR-Cas9 Gene Editing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global CRISPR-Cas9 Gene Editing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global CRISPR-Cas9 Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Type (2021-2026) Table 31. Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Type (2027-2032) Table 32. Global CRISPR-Cas9 Gene Editing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global CRISPR-Cas9 Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Application (2021-2026) Table 36. Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Application (2027-2032) Table 37. AMSBIO Company Information Table 38. AMSBIO Business Overview Table 39. AMSBIO CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. AMSBIO CRISPR-Cas9 Gene Editing Service Product Portfolio Table 41. AMSBIO Recent Development Table 42. GenScript Company Information Table 43. GenScript Business Overview Table 44. GenScript CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. GenScript CRISPR-Cas9 Gene Editing Service Product Portfolio Table 46. GenScript Recent Development Table 47. Merck Company Information Table 48. Merck Business Overview Table 49. Merck CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Merck CRISPR-Cas9 Gene Editing Service Product Portfolio Table 51. Merck Recent Development Table 52. Editas Medicine Company Information Table 53. Editas Medicine Business Overview Table 54. Editas Medicine CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Editas Medicine CRISPR-Cas9 Gene Editing Service Product Portfolio Table 56. Editas Medicine Recent Development Table 57. Intellia Therapeutics Company Information Table 58. Intellia Therapeutics Business Overview Table 59. Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio Table 61. Intellia Therapeutics Recent Development Table 62. CRISPR Therapeutics Company Information Table 63. CRISPR Therapeutics Business Overview Table 64. CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio Table 66. CRISPR Therapeutics Recent Development Table 67. DefiniGEN Company Information Table 68. DefiniGEN Business Overview Table 69. DefiniGEN CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. DefiniGEN CRISPR-Cas9 Gene Editing Service Product Portfolio Table 71. DefiniGEN Recent Development Table 72. Synthego Company Information Table 73. Synthego Business Overview Table 74. Synthego CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Synthego CRISPR-Cas9 Gene Editing Service Product Portfolio Table 76. Synthego Recent Development Table 77. Biocytogen Company Information Table 78. Biocytogen Business Overview Table 79. Biocytogen CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Biocytogen CRISPR-Cas9 Gene Editing Service Product Portfolio Table 81. Biocytogen Recent Development Table 82. Caribou Company Information Table 83. Caribou Business Overview Table 84. Caribou CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Caribou CRISPR-Cas9 Gene Editing Service Product Portfolio Table 86. Caribou Recent Development Table 87. Horizo​​n Discovery Ltd. Company Information Table 88. Horizo​​n Discovery Ltd. Business Overview Table 89. Horizo​​n Discovery Ltd. CRISPR-Cas9 Gene Editing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Horizo​​n Discovery Ltd. CRISPR-Cas9 Gene Editing Service Product Portfolio Table 91. Horizo​​n Discovery Ltd. Recent Development Table 92. EdiGene, Inc. Company Information Table 93. EdiGene, Inc. Business Overview Table 94. EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Product Portfolio Table 96. EdiGene, Inc. Recent Development Table 97. DetaiBio Company Information Table 98. DetaiBio Business Overview Table 99. DetaiBio CRISPR-Cas9 Gene Editing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. DetaiBio CRISPR-Cas9 Gene Editing Service Product Portfolio Table 101. DetaiBio Recent Development Table 102. North America CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 103. North America CRISPR-Cas9 Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 104. North America CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 105. North America CRISPR-Cas9 Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 106. North America CRISPR-Cas9 Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America CRISPR-Cas9 Gene Editing Service Revenue by Country (2021-2026) & (US$ Million) Table 108. North America CRISPR-Cas9 Gene Editing Service Revenue by Country (US$ Million) & (2027-2032) Table 109. Europe CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe CRISPR-Cas9 Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe CRISPR-Cas9 Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe CRISPR-Cas9 Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe CRISPR-Cas9 Gene Editing Service Revenue by Country (2021-2026) & (US$ Million) Table 115. Europe CRISPR-Cas9 Gene Editing Service Revenue by Country (US$ Million) & (2027-2032) Table 116. China CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 117. China CRISPR-Cas9 Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 118. China CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 119. China CRISPR-Cas9 Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia CRISPR-Cas9 Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 123. Asia CRISPR-Cas9 Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia CRISPR-Cas9 Gene Editing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Asia CRISPR-Cas9 Gene Editing Service Revenue by Region (US$ Million) & (2021-2026) Table 126. Asia CRISPR-Cas9 Gene Editing Service Revenue by Region (US$ Million) & (2027-2032) Table 127. SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 128. SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 129. SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 130. SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 131. SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Country (2021-2026) & (US$ Million) Table 133. SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Country (US$ Million) & (2027-2032) Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. CRISPR-Cas9 Gene Editing Service Image Figure 2. Global CRISPR-Cas9 Gene Editing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global CRISPR-Cas9 Gene Editing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Knock-in Gene Editing Service Image Figure 5. Knock-out Gene Editing Service Image Figure 6. Other Image Figure 7. Global CRISPR-Cas9 Gene Editing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global CRISPR-Cas9 Gene Editing Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cell Line Construction Image Figure 10. Animal Models Image Figure 11. Bioagriculture Image Figure 12. Other Image Figure 13. Global CRISPR-Cas9 Gene Editing Service Market Size (US$ Million) & (2021-2032) Figure 14. Global CRISPR-Cas9 Gene Editing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global CRISPR-Cas9 Gene Editing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global CRISPR-Cas9 Gene Editing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global CRISPR-Cas9 Gene Editing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global CRISPR-Cas9 Gene Editing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Type (2021-2032) Figure 21. Global CRISPR-Cas9 Gene Editing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Application (2021-2032) Figure 24. North America CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America CRISPR-Cas9 Gene Editing Service Revenue Share by Type (2021-2032) Figure 26. North America CRISPR-Cas9 Gene Editing Service Revenue Share by Application (2021-2032) Figure 27. North America CRISPR-Cas9 Gene Editing Service Revenue Share by Country (2021-2032) Figure 28. United States CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe CRISPR-Cas9 Gene Editing Service Revenue Share by Type (2021-2032) Figure 33. Europe CRISPR-Cas9 Gene Editing Service Revenue Share by Application (2021-2032) Figure 34. Europe CRISPR-Cas9 Gene Editing Service Revenue Share by Country (2021-2032) Figure 35. Germany CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China CRISPR-Cas9 Gene Editing Service Revenue Share by Type (2021-2032) Figure 45. China CRISPR-Cas9 Gene Editing Service Revenue Share by Application (2021-2032) Figure 46. Asia CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia CRISPR-Cas9 Gene Editing Service Revenue Share by Type (2021-2032) Figure 48. Asia CRISPR-Cas9 Gene Editing Service Revenue Share by Application (2021-2032) Figure 49. Asia CRISPR-Cas9 Gene Editing Service Revenue Share by Region (2021-2032) Figure 50. Japan CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA CRISPR-Cas9 Gene Editing Service Revenue Share by Type (2021-2032) Figure 58. SAMEA CRISPR-Cas9 Gene Editing Service Revenue Share by Application (2021-2032) Figure 59. SAMEA CRISPR-Cas9 Gene Editing Service Revenue Share by Country (2021-2032) Figure 60. Brazil CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt CRISPR-Cas9 Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Knock-in Gene Editing Service
  • Knock-out Gene Editing Service
  • Other
Applications
  • Cell Line Construction
  • Animal Models
  • Bioagriculture
  • Other
Companies covered
  • AMSBIO
  • GenScript
  • Merck
  • Editas Medicine
  • Intellia Therapeutics
  • CRISPR Therapeutics
  • DefiniGEN
  • Synthego
  • Biocytogen
  • Caribou
  • Horizo​​n Discovery Ltd.
  • EdiGene, Inc.
  • DetaiBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 CRISPR-Cas9 Gene Editing Service Market by Type
  3. 1.2.1 Global CRISPR-Cas9 Gene Editing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Knock-in Gene Editing Service
  5. 1.2.3 Knock-out Gene Editing Service
  6. 1.2.4 Other
  7. 1.3 CRISPR-Cas9 Gene Editing Service Market by Application
  8. 1.3.1 Global CRISPR-Cas9 Gene Editing Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cell Line Construction
  10. 1.3.3 Animal Models
  11. 1.3.4 Bioagriculture
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 CRISPR-Cas9 Gene Editing Service Market Dynamics
  1. 2.1 CRISPR-Cas9 Gene Editing Service Industry Trends
  2. 2.2 CRISPR-Cas9 Gene Editing Service Industry Drivers
  3. 2.3 CRISPR-Cas9 Gene Editing Service Industry Opportunities and Challenges
  4. 2.4 CRISPR-Cas9 Gene Editing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global CRISPR-Cas9 Gene Editing Service Market Perspective (2021-2032)
  2. 3.2 Global CRISPR-Cas9 Gene Editing Service Growth Trends by Region
  3. 3.2.1 Global CRISPR-Cas9 Gene Editing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global CRISPR-Cas9 Gene Editing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global CRISPR-Cas9 Gene Editing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global CRISPR-Cas9 Gene Editing Service Revenue by Players
  2. 4.1.1 Global CRISPR-Cas9 Gene Editing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global CRISPR-Cas9 Gene Editing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global CRISPR-Cas9 Gene Editing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global CRISPR-Cas9 Gene Editing Service Key Players Headquarters & Area Served
  7. 4.4 Global CRISPR-Cas9 Gene Editing Service Players, Product Type & Application
  8. 4.5 Global CRISPR-Cas9 Gene Editing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global CRISPR-Cas9 Gene Editing Service Market CR5 and HHI
  11. 4.6.3 2025 CRISPR-Cas9 Gene Editing Service Tier 1, Tier 2, and Tier 3
5 CRISPR-Cas9 Gene Editing Service Market Size by Type
  1. 5.1 Global CRISPR-Cas9 Gene Editing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2032)
  3. 5.3 Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Type (2021-2032)
6 CRISPR-Cas9 Gene Editing Service Market Size by Application
  1. 6.1 Global CRISPR-Cas9 Gene Editing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2032)
  3. 6.3 Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AMSBIO
  2. 7.1.1 AMSBIO Company Information
  3. 7.1.2 AMSBIO Business Overview
  4. 7.1.3 AMSBIO CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AMSBIO CRISPR-Cas9 Gene Editing Service Product Portfolio
  6. 7.1.5 AMSBIO Recent Developments
  7. 7.2 GenScript
  8. 7.2.1 GenScript Company Information
  9. 7.2.2 GenScript Business Overview
  10. 7.2.3 GenScript CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GenScript CRISPR-Cas9 Gene Editing Service Product Portfolio
  12. 7.2.5 GenScript Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Merck CRISPR-Cas9 Gene Editing Service Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Editas Medicine
  20. 7.4.1 Editas Medicine Company Information
  21. 7.4.2 Editas Medicine Business Overview
  22. 7.4.3 Editas Medicine CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Editas Medicine CRISPR-Cas9 Gene Editing Service Product Portfolio
  24. 7.4.5 Editas Medicine Recent Developments
  25. 7.5 Intellia Therapeutics
  26. 7.5.1 Intellia Therapeutics Company Information
  27. 7.5.2 Intellia Therapeutics Business Overview
  28. 7.5.3 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
  30. 7.5.5 Intellia Therapeutics Recent Developments
  31. 7.6 CRISPR Therapeutics
  32. 7.6.1 CRISPR Therapeutics Company Information
  33. 7.6.2 CRISPR Therapeutics Business Overview
  34. 7.6.3 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
  36. 7.6.5 CRISPR Therapeutics Recent Developments
  37. 7.7 DefiniGEN
  38. 7.7.1 DefiniGEN Company Information
  39. 7.7.2 DefiniGEN Business Overview
  40. 7.7.3 DefiniGEN CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 DefiniGEN CRISPR-Cas9 Gene Editing Service Product Portfolio
  42. 7.7.5 DefiniGEN Recent Developments
  43. 7.8 Synthego
  44. 7.8.1 Synthego Company Information
  45. 7.8.2 Synthego Business Overview
  46. 7.8.3 Synthego CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Synthego CRISPR-Cas9 Gene Editing Service Product Portfolio
  48. 7.8.5 Synthego Recent Developments
  49. 7.9 Biocytogen
  50. 7.9.1 Biocytogen Company Information
  51. 7.9.2 Biocytogen Business Overview
  52. 7.9.3 Biocytogen CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Biocytogen CRISPR-Cas9 Gene Editing Service Product Portfolio
  54. 7.9.5 Biocytogen Recent Developments
  55. 7.10 Caribou
  56. 7.10.1 Caribou Company Information
  57. 7.10.2 Caribou Business Overview
  58. 7.10.3 Caribou CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Caribou CRISPR-Cas9 Gene Editing Service Product Portfolio
  60. 7.10.5 Caribou Recent Developments
  61. 7.11 Horizo​​n Discovery Ltd.
  62. 7.11.1 Horizo​​n Discovery Ltd. Company Information
  63. 7.11.2 Horizo​​n Discovery Ltd. Business Overview
  64. 7.11.3 Horizo​​n Discovery Ltd. CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Horizo​​n Discovery Ltd. CRISPR-Cas9 Gene Editing Service Product Portfolio
  66. 7.11.5 Horizo​​n Discovery Ltd. Recent Developments
  67. 7.12 EdiGene, Inc.
  68. 7.12.1 EdiGene, Inc. Company Information
  69. 7.12.2 EdiGene, Inc. Business Overview
  70. 7.12.3 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Product Portfolio
  72. 7.12.5 EdiGene, Inc. Recent Developments
  73. 7.13 DetaiBio
  74. 7.13.1 DetaiBio Company Information
  75. 7.13.2 DetaiBio Business Overview
  76. 7.13.3 DetaiBio CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 DetaiBio CRISPR-Cas9 Gene Editing Service Product Portfolio
  78. 7.13.5 DetaiBio Recent Developments
8 North America
  1. 8.1 North America CRISPR-Cas9 Gene Editing Service Revenue (2021-2032)
  2. 8.2 North America CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America CRISPR-Cas9 Gene Editing Service Revenue by Type (2027-2032)
  5. 8.3 North America CRISPR-Cas9 Gene Editing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America CRISPR-Cas9 Gene Editing Service Revenue by Application (2027-2032)
  9. 8.5 North America CRISPR-Cas9 Gene Editing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America CRISPR-Cas9 Gene Editing Service Revenue by Country
  11. 8.6.1 North America CRISPR-Cas9 Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America CRISPR-Cas9 Gene Editing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America CRISPR-Cas9 Gene Editing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe CRISPR-Cas9 Gene Editing Service Revenue (2021-2032)
  2. 9.2 Europe CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe CRISPR-Cas9 Gene Editing Service Revenue by Type (2027-2032)
  5. 9.3 Europe CRISPR-Cas9 Gene Editing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe CRISPR-Cas9 Gene Editing Service Revenue by Application (2027-2032)
  9. 9.5 Europe CRISPR-Cas9 Gene Editing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe CRISPR-Cas9 Gene Editing Service Revenue by Country
  11. 9.6.1 Europe CRISPR-Cas9 Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe CRISPR-Cas9 Gene Editing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe CRISPR-Cas9 Gene Editing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China CRISPR-Cas9 Gene Editing Service Revenue (2021-2032)
  2. 10.2 China CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2032)
  3. 10.2.1 China CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2026)
  4. 10.2.2 China CRISPR-Cas9 Gene Editing Service Revenue by Type (2027-2032)
  5. 10.3 China CRISPR-Cas9 Gene Editing Service Revenue Share by Type (2021-2032)
  6. 10.4 China CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2032)
  7. 10.4.1 China CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2026)
  8. 10.4.2 China CRISPR-Cas9 Gene Editing Service Revenue by Application (2027-2032)
  9. 10.5 China CRISPR-Cas9 Gene Editing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia CRISPR-Cas9 Gene Editing Service Revenue (2021-2032)
  2. 11.2 Asia CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia CRISPR-Cas9 Gene Editing Service Revenue by Type (2027-2032)
  5. 11.3 Asia CRISPR-Cas9 Gene Editing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia CRISPR-Cas9 Gene Editing Service Revenue by Application (2027-2032)
  9. 11.5 Asia CRISPR-Cas9 Gene Editing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia CRISPR-Cas9 Gene Editing Service Revenue by Country
  11. 11.6.1 Asia CRISPR-Cas9 Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia CRISPR-Cas9 Gene Editing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia CRISPR-Cas9 Gene Editing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA CRISPR-Cas9 Gene Editing Service Revenue (2021-2032)
  2. 12.2 SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA CRISPR-Cas9 Gene Editing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA CRISPR-Cas9 Gene Editing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Country
  11. 12.6.1 SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA CRISPR-Cas9 Gene Editing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst